In the aggressive form of glioma, glioblastoma multiforme (GBM), from which the T98G and U87MG cell lines are derived, high NMNAT1-expressing tumors (top 10%) again showed a significant correlation with more aggressive disease and poorer outcome (Figure 11C). This evidence concerns the gene NMNAT1 and central nervous system cancer.